James Condulis
Stock Analyst at Stifel Nicolaus
Total Price Targets
4
Stocks Covered
4
Sectors
Healthcare
Most Recent
Feb 26, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by James Condulis
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | $25.00 | $30.63 | -18.4% | 1 | Feb 26, 2026 |
| XFOR | X4 Pharmaceuticals, Inc. | $10.00 | $4.20 | +138.1% | 1 | Dec 5, 2025 |
| CYTK | Cytokinetics, Incorporated | $96.00 | $64.40 | +49.1% | 1 | Sep 2, 2025 |
| MIRM | Mirum Pharmaceuticals, Inc. | $89.00 | $97.47 | -8.7% | 1 | Aug 11, 2025 |
Recent Activity
Frequently Asked Questions
Who is James Condulis?
James Condulis is a stock analyst at Stifel Nicolaus covering 4 stocks primarily in Healthcare. They have issued 4 price targets since Aug 11, 2025.
What stocks does James Condulis cover?
James Condulis currently covers 4 stocks, including EWTX, XFOR, CYTK, MIRM.
What is James Condulis's latest price target?
James Condulis's most recent price target was $25.00 on EWTX (Edgewise Therapeutics, Inc.), set on Feb 26, 2026.
What is James Condulis's highest price target?
James Condulis's highest issued price target is $96.00 on CYTK, set on Sep 2, 2025.
More Analysts at Stifel Nicolaus
Coverage based on publicly published price targets. Not investment advice.